Insider Transactions in Q1 2023 at 89bio, Inc. (ETNB)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,443
-5.11%
|
$231,645
$15.23 P/Share
|
|
Mar 31
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+9.93%
|
-
|
|
Mar 31
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,612
-3.7%
|
$69,180
$15.23 P/Share
|
|
Mar 31
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+9.65%
|
-
|
|
Mar 31
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
4,179
-2.09%
|
$62,685
$15.23 P/Share
|
|
Mar 31
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
12,083
+5.66%
|
-
|
|
Mar 31
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-2.8%
|
$43,230
$15.23 P/Share
|
|
Mar 31
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+7.48%
|
-
|
|
Mar 28
2023
|
Michael R Hayden |
BUY
Open market or private purchase
|
Indirect |
61,538
+50.0%
|
$984,608
$16.15 P/Share
|
|
Mar 24
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,461,538
+18.18%
|
$39,384,608
$16.25 P/Share
|
|
Mar 23
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-8.54%
|
$80,000
$16.11 P/Share
|
|
Mar 23
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.28%
|
$240,000
$16.0 P/Share
|
|
Mar 01
2023
|
Edward Morrow Atkinson Iii |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$130,000
$13.6 P/Share
|
|
Mar 01
2023
|
Edward Morrow Atkinson Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$40,000
$4.44 P/Share
|
|
Feb 21
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,540
-4.16%
|
$33,020
$13.89 P/Share
|
|
Feb 17
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-2.29%
|
$27,820
$13.97 P/Share
|
|
Feb 17
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,750
-2.78%
|
$22,750
$13.97 P/Share
|
|
Feb 17
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-2.2%
|
$27,651
$13.97 P/Share
|
|
Feb 17
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,279
-2.16%
|
$81,627
$13.97 P/Share
|
|
Feb 09
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+20.53%
|
-
|
|
Feb 09
2023
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+23.66%
|
-
|
|
Feb 09
2023
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+32.3%
|
-
|
|
Feb 09
2023
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+24.33%
|
-
|
|
Feb 08
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,480
-4.31%
|
$20,720
$14.41 P/Share
|
|
Feb 05
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,390
-2.15%
|
$18,070
$13.24 P/Share
|
|
Feb 05
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-1.69%
|
$7,696
$13.24 P/Share
|
|
Feb 05
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,078
-1.86%
|
$53,014
$13.24 P/Share
|
|
Feb 05
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,360
-2.0%
|
$17,680
$13.24 P/Share
|
|
Feb 03
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,592
-4.4%
|
$43,104
$12.91 P/Share
|
|
Feb 03
2023
|
Ryan Martins Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.15%
|
$9,000
$3.11 P/Share
|
|
Feb 01
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.99%
|
$8,160
$12.05 P/Share
|
|
Feb 01
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-1.12%
|
$4,896
$12.05 P/Share
|
|
Feb 01
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-1.06%
|
$8,340
$12.05 P/Share
|
|
Jan 03
2023
|
Ryan Martins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,947
-14.05%
|
$71,364
$12.51 P/Share
|